BERKELEY, Calif., Oct. 30, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief Executive Officer of XOMA, is scheduled to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The presentation will take place in New York on Tuesday, November 6 at 10:55 a.m. Eastern time.